Form 4 for CTAS Cintas
Accepted 2021-10-14 00:00:00 ET · period of report 2021-10-12 · accession 0001567619-21-018286 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-10-14 | 2021-10-12 | CTAS | Schneider Todd M. | CEO, Dir | M - OptEx | $153.48 | +32.0K | 146.3K | +28% | +$4.90M |
| DM | 2021-10-14 | 2021-10-12 | CTAS | Schneider Todd M. | CEO, Dir | S - Sale+OE | $403.99 | -21.2K | 125.1K | -14% | -$8.55M |
| DM | 2021-10-14 | 2021-10-12 | CTAS | Schneider Todd M. | CEO, Dir | M - OptEx | $0.00 | -32.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-12 | M | A | 9,900 | $108.39 | 124,199 | D | — | — | |
| 2 | Common | Common Stock | 2021-10-12 | M | A | 10,432 | $137.30 | 134,631 | D | — | — | |
| 3 | Common | Common Stock | 2021-10-12 | M | A | 8,881 | $206.99 | 143,512 | D | — | — | |
| 4 | Common | Common Stock | 2021-10-12 | M | A | 2,745 | $204.48 | 146,257 | D | — | — | |
| 5 | Common | Common Stock | 2021-10-12 | S | D | 18,486 | $403.84 | 127,771 | D | — | — | (F1) The Reported Price is a weighted price. These shares were sold in multiple transactions ranging from $403.40 to $404.35. The Reporting Person undertakes to provide full pricing information to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission upon request. |
| 6 | Common | Common Stock | 2021-10-12 | S | D | 2,668 | $405.01 | 125,103 | D | — | — | (F2) The Reported Price is a weighted price. These shares were sold in multiple transactions ranging from $404.46 to $405.33. The Reporting Person undertakes to provide full pricing information to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission upon request. |
| 7 | Derivative | Stock Option (Right to Buy) | 2021-10-12 | M | D | 10,432 | $0.00 | 10,434 | D | $137.30 · — to 2027-07-25 | 10,432 Common Stock | (F4) The options vest as follows: one-third on the third anniversary of the grant date, one-third on the fourth anniversary of the grant date, and one-third on the fifth anniversary of the grant date. |
| 8 | Derivative | Stock Option (Right to Buy) | 2021-10-12 | M | D | 8,881 | $0.00 | 17,762 | D | $206.99 · — to 2028-07-24 | 8,881 Common Stock | (F4) The options vest as follows: one-third on the third anniversary of the grant date, one-third on the fourth anniversary of the grant date, and one-third on the fifth anniversary of the grant date. |
| 9 | Derivative | Stock Option (Right to Buy) | 2021-10-12 | M | D | 2,745 | $0.00 | 5,492 | D | $204.48 · — to 2028-07-31 | 2,745 Common Stock | (F4) The options vest as follows: one-third on the third anniversary of the grant date, one-third on the fourth anniversary of the grant date, and one-third on the fifth anniversary of the grant date. |
| 10 | Derivative | Stock Option (Right to Buy) | 2021-10-12 | M | D | 9,900 | $0.00 | 0 | D | $108.39 · — to 2026-07-26 | 9,900 Common Stock | (F4) The options vest as follows: one-third on the third anniversary of the grant date, one-third on the fourth anniversary of the grant date, and one-third on the fifth anniversary of the grant date. |